NCT03769090

Phase 3Interventional

Includes trials conducted after preliminary evidence suggesting effectiveness of the drug has been obtained, and are intended to gather additional information to evaluate the overall benefit-risk relationship of the drug.

View on ClinicalTrials.gov ↗

Timeline

Start date: Dec 27, 2018
Primary completion: Sep 15, 2020
Completion date: Dec 1, 2020
First posted: —
Last posted: —
Enrollment: 3100
Arms / groups: 3 / —
Source: AACT · ingestion pipeline

Drugs studied

albuterol
budesonide

Indications studied

Asthma

CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.

NCT03769090

Timeline

Sponsors

Drugs studied

Indications studied